NEW YORK, Jan. 4, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 15 companies including many key and niche players such as -
Animas Corp.
Debiotech S.A.
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic Plc
Read the full report: http://www.reportlinker.com/p04484178-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Insulin Pumps: A Prelude..............II-1 The United States - The Largest Market II-2 Europe - A Market with Vast Potential II-3 Lower Current Penetration Leaves Significant Room for Growth II-3 Table 1: Insulin Pumps Market by Region (2013): Percentage Breakdown of Number of Users of Insulin Pumps for Established Markets and Rest of World (includes corresponding Graph/Chart).............. II-4
Table 2: Insulin Pump Penetration Rate in Type 1 Diabetic Patients by Country (2013): Number of Users as a Share of Population for Select Leading Countries (includes corresponding Graph/Chart)..............II-4 Rising Incidence of Diabetes - A Major Market Driving Factor II-4 Table 3: Global Diabetic Population by Region (2015 & 2040) (includes corresponding Graph/Chart) II-6
Table 4: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2015 (includes corresponding Graph/Chart) II-7
Table 5: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2040 (includes corresponding Graph/Chart) II-7 Diabetes - Assessing the Economic Burden II-8 Table 6: Diabetes Related Healthcare Expenditure by Region: 2015 & 2040 (in US$ Billion) (includes corresponding Graph/Chart).............. II-8
Table 7: Major Spenders on Diabetes (2015): Annual Expenditure on Diabetes Treatment and Management in US$ Billion for Ten Leading Countries (includes corresponding Graph/Chart).............. II-9
2. COMPETITIVE ANALYSIS.............. II-10 Insulin Pumps Market - Set for Interesting Road Ahead II-10 Table 8: Leading Players in the Global Market for External Insulin Pumps (2015E): Percentage Breakdown of Value Sales for Insulet, J&J (Animas), Medtronic, Roche, Tandem and Others (includes corresponding Graph/Chart) II-11 Comparison of Select Durable Insulin Pumps by Manufacturer II-11 Medtronic Banks on New Solutions and Distribution Expansion to Retain Dominance.............. II-12 J&J's OneTouch Via - A Discrete Solution for On-Demand Insulin II-12 Tandem Sees Gradual Rise in Market Share II-13 Ypsomed Eyes Brighter Prospects with YpsoPump II-13 Medtrum - A New Entrant with a Strong Product; Threatening to Take the Market by Storm..............II-14 Competitive Landscape in the Insulin Patch Pump Market II-15 OmniPod Benefits from Lack of Close Competition in its League II-15 Insulet Focuses on Advances in Technology and Services to Gain Market Share.............. II-15 Cellnovo's Patch Pump Combines Functionality and Cost- Effectiveness.............. II-16 V-Go - An Affordable Patch Pump for Type II Diabetics II-17 Valeritas Struggles to Push Sales of V-Go II-17 Tough Ground for New Entrants..............II-18
3. MARKET TRENDS AND ISSUES..............II-19 Type II Diabetes - A Market with Significant Potential II-19 Patch Pumps Gain Manufacturer Attention II-19 Prefilled Insulin Cartridges Gain Popularity over Manual Filling II-20 The Rise of Smart Pumps - A Major Game Changer II-20 Innovative Features Spruce Up the Market for Insulin Pumps II-21 Artificial Pancreas System (APS) - The Future of Diabetes Care II-21 Artificial Pancreas - Are We There Yet? II-22 The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps..............II-22 Table 9: Percentage Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart)..............II-23
Table 10: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart) II-24
Table 11: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart) II-25
Table 12: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart) II-26 Alarming Rise in Obesity - A Business Case for Diabetes Care II-26 Table 13: World Obesity Prevalence (2015 & 2022): Percentage of Obese Population for Leading Ten Countries (includes corresponding Graph/Chart)..............II-27 Diabetes in Developing Countries to Expand Opportunities II-28
4. KEY MARKET DRIVERS AND CHALLENGES II-29 ICR: A Key Factor to Success..............II-29 Customer Satisfaction: Crucial to Stay Competitive II-29 Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.............. II-29 Undiagnosed Diabetes - A Key Challenge II-29 Better Safety Review - A Growing Need for Insulin Pumps II-30 Insulin Pump Training - Not Receiving Adequate Attention II-30 Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.............. II-30 Competition from Other Insulin Delivery Technologies Continues II-31 Implantable Insulin Pumps - A Potential Threat to External Insulin Pumps.............. II-31 Lantus: A Threat to Insulin Pump Manufacturers II-32
5. DIABETES & INSULIN - AN ABSTRACT..............II-33 Diabetes - A Fatal Disease..............II-33 Risk Factors for Diabetes..............II-33 Types of Diabetes.............. II-33 Long Term Complications of Diabetes II-34 Testing Sugar Levels: Easy and Accurate II-34 Insulin.............. II-34 Pancreas: The Main Source of Insulin in Human Body II-34 Types of Insulin.............. II-35 Types of Insulin & Onset of Action II-35 Goal of Insulin Therapy..............II-35 Insulin Delivery Systems..............II-35 a. Syringes.............. II-36 b. Insulin Pens.............. II-37 c. Jet Injectors.............. II-37 d. Tablets.............. II-37 e. External Insulin Pumps..............II-37 f. Artificial Pancreas..............II-38 Insulin Delivery Technologies..............II-38
6. PRODUCT OVERVIEW.............. II-39 Evolution of Insulin Pumps..............II-39 Components of Insulin Pump..............II-39 How Does an Insulin Pump Work? II-40 Value-added Features of Modern Insulin Pumps II-40 Bolus Calculators.............. II-40 Insulin on Board..............II-40 Customized Alarms.............. II-40 Touch Bolus.............. II-41 Interface to PCs..............II-41 Others.............. II-41 Insulin Pump Delivery Rates..............II-41 Guidelines for Insulin Pump Usage II-41 Advantages.............. II-42 More Accurate and Consistent..............II-42 Enhances Blood Sugar Control in Pediatric Patients II-42 Adjusting Time Zones While Traveling II-43 Improves Quality of Life..............II-43 Patient Convenience..............II-43 Other Advantages.............. II-43 Disadvantages/Risks Involved in the Usage of Insulin Pumps II-44 High Cost.............. II-44 High Involvement.............. II-44 Diabetic Ketoacidosis Risk..............II-44 Glucose Testing at Regular Intervals II-44 Regular Rotation of Infusion Set II-44 Carrying Back-up Kit..............II-45 Regular Refilling of Pump..............II-45 Other Disadvantages..............II-45
7. PRODUCT INNOVATIONS/INTRODUCTIONS II-46 Cellnovo Files FDA 510(k) Clearance for Diabetes Management System.............. II-46 Medtronic Obtains FDA Nod for its New MiniMed® 670G System II-46 Medtrum Launches Medtrum P6 Tubeless Insulin Pump II-46 Medtronic Launches MiniMed® 630G System II-46 Tandem Secures FDA Expanded Indication for t:slim® Insulin Pump II-46 EMA Clears Use of mylife™ YpsoPump® with NovoRapid® PumpCart® II-46 Animas Receives FDA Expanded Indication for Animas® Vibe® Insulin Pump in Children..............II-46 Medtronic Introduces MiniMed Connect System for Insulin Pumps and CGMs.............. II-47 Tandem Gets FDA Nod for t:slim G4 Insulin Pump II-47 Unilife Rolls Out Instant Patch Pumps Platform - Imperium™ II-47 Medtronic Rolls Out MiniMed™ 640G System II-47 Tandem Bags FDA Clearance for t:flex Insulin Pump II-47 Roche Rolls Out Accu-Chek Insight Insulin Pump System in the UK II-47 J&J Animas Obtains FDA Approval for Vibe Insulin Pump II-47 Novo Nordisk Launches NovoRapid® PumpCart® Prefilled Cartridge II-48 Medtronic Introduces Arabic-Enabled Insulin Pump II-48 Medtronic Launches MiniMed® Duo™ in Europe II-48 Animas Secures CE Mark for Animas® Vibe™ Insulin Pump II-48 Cellnovo Introduces Novel Insulin Pump System in the UK II-48 Debiotech to Unveil JewelPump2 II-48 J&J Introduces Animas Vibe in Canada II-48
8. RECENT INDUSTRY ACTIVITY..............II-49 Tandem Announces Order Intake for t:slim X2™ Insulin Pump II-49 Bigfoot Secure FDA's Clearance for Artificial Pancreas Trial II-49 Tandem Inks Technology Licensing Deal with TypeZero II-49 Ypsomed and Novo Nordisk Sign Pact for mylife™ YpsoPump® II-49 UnitedHealth Group Selects Medtronic As Exclusive Supplier of Insulin Pumps.............. II-49 Cellnovo and Roche Enter into Commercial Agreement for BGM II-49 Insulet Inks Deal with Mode for Licensing Artificial Pancreas Algorithm.............. II-50 Ypsomed Expands Availability of mylife™ OmniPod® in Europe II-50 Medtronic Enters into Agreement with Chengdu Government to Produce Insulin Pumps..............II-50 Insulet and Eli Lilly Team Up to Develop New Version of OmniPod for Delivering Lilly's Humalog II-50 Tandem and Dexcom Ink Deal to Pair their Devices II-50 BD Medical and Medtronic Collaborate to Launch New Infusion Set II-50 Bigfoot Biomedical Takes Over Asante Solutions II-50 Debiotech to Take Over Rights to iSense CGM II-51 Medtronic Acquires Covidien..............II-51
9. FOCUS ON SELECT PLAYERS..............II-52 Animas Corp. (USA)..............II-52 Debiotech S.A. (Switzerland)..............II-52 F. Hoffmann-La Roche, Ltd. (Switzerland) II-52 Insulet Corp. (USA).............. II-53 Medtronic Plc. (Ireland)..............II-53 Sooil Development Co. Ltd. (Korea) II-54 Tandem Diabetes Care Inc. (USA)..............II-54 Valeritas Inc. (US).............. II-55 Ypsomed Holding AG (Switzerland) II-55
10. GLOBAL MARKET PERSPECTIVE..............II-56 Table 14: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-56
Table 15: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-57
Table 16: World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-58
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Current & Future Analysis..............III-1 Table 17: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart) III-1
Table 18: The US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart) III-2
Table 19: US Market for Diabetes Management (2015 & 2018P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart)..............III-3
Table 20: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)..............III-3 Increasing Inclination towards Patch Pumps III-3 Artificial Pancreas System (APS): The Future of Diabetes Management.............. III-4 Select Clinical Studies on Artificial Pancreas Technology III-4 Competitive Scenario..............III-4 Table 21: Leading Players in the US Insulin Pump Market (2014): Percentage Breakdown of Installed Base by Company (includes corresponding Graph/Chart) III-5 Comparison of Select Insulin Pump Systems Available in the US III-5 Reimbursements.............. III-5 Regulatory Scenario..............III-6 FDA Announces a New Mandate for Manufacturing Companies III-6 Product Approvals/Launches..............III-6 Strategic Corporate Developments III-8 Select Key Players..............III-9 B.Market Analytics..............III-11 Table 22: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-11
Table 23: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-12
2. CANADA.............. III-13 A.Market Analysis.............. III-13 Current & Future Analysis..............III-13 Diabetes Statistics..............III-13 Table 24: Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart) III-13
Table 25: Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart)..............III-14 Product Launch.............. III-14 B.Market Analytics..............III-15 Table 26: Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-15
Table 27: Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-16
3. EUROPE.............. III-17 A.Market Analysis.............. III-17 Current & Future Analysis..............III-17 Market Overview.............. III-17 Regional Scenario..............III-18 Diabetes Prevalence in Europe..............III-18 Table 28: Diabetes Prevalence in Europe (2015): Prevalence of Type I & Type II Diabetes As Percentage of Adult Population (Aged 20 to 79 Years) by Country (includes corresponding Graph/Chart)..............III-19 Product Approvals.............. III-20 B.Market Analytics..............III-21 Table 29: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-21
Table 30: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-22
Table 31: European 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-23
3a. FRANCE.............. III-24 A.Market Analysis.............. III-24 Current & Future Analysis..............III-24 Strategic Corporate Development III-24 B.Market Analytics..............III-25 Table 32: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-25
Table 33: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-26
3b. GERMANY.............. III-27 Market Analysis.............. III-27 Table 34: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-27
Table 35: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-28
3c. ITALY.............. III-29 Market Analysis.............. III-29 Table 36: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-29
Table 37: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-30
3d. THE UNITED KINGDOM..............III-31 A.Market Analysis.............. III-31 Current & Future Analysis..............III-31 INPUT (The Insulin Pump Therapy Group) III-31 NICE (National Institute of Clinical Excellence) III-31 Product Launches..............III-32 B.Market Analytics..............III-33 Table 38: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-33
Table 39: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-34
3e. SPAIN.............. III-35 Market Analysis.............. III-35 Table 40: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-35
Table 41: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-36
3f. RUSSIA.............. III-37 Market Analysis.............. III-37 Table 42: Russian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-37
Table 43: Russian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-38
3g. REST OF EUROPE.............. III-39 A.Market Analysis.............. III-39 Current & Future Analysis..............III-39 Diabetes in Russia..............III-39 Product Launches..............III-39 Strategic Corporate Developments III-40 Select Key Players..............III-40 B.Market Analytics..............III-43 Table 44: Rest of European Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-43
Table 45: Rest of European Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-44
4. ASIA-PACIFIC.............. III-45 A.Market Analysis.............. III-45 Current & Future Analysis..............III-45 Table 46: Diabetes in Asia-Pacific (2015): Number of People with Diabetes for Select Countries (includes corresponding Graph/Chart).............. III-45 Review of Select Markets..............III-46 China.............. III-46 Overview.............. III-46 China: An Untapped Goldmine..............III-46 India.............. III-46 Diabetes Scenario..............III-46 Insulin Pumps Market in India - An Overview III-47 New Indigenously Developed Product Could be the Answer III-47 Medtronic: The Current Market Leader III-47 Diabetic Epidemic Spurs Indian Market III-48 Strategic Corporate Development III-48 Key Player.............. III-49 B.Market Analytics..............III-49 Table 47: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-49
Table 48: Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-50
5. LATIN AMERICA.............. III-51 A.Market Analysis.............. III-51 Current & Future Analysis..............III-51 A Peek in to the Brazilian Insulin Pumps Market III-51 B.Market Analytics..............III-52 Table 49: Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-52
Table 50: Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-53
6. REST OF WORLD.............. III-54 A.Market Analysis.............. III-54 Current & Future Analysis..............III-54 Demand for Insulin Pumps Surges in the UAE III-54 B.Market Analytics..............III-54 Table 51: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-54
Table 52: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-55
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 15 (including Divisions/Subsidiaries - 18)
The United States (11) Europe (6) - France (1) - The United Kingdom (1) - Rest of Europe (4) Asia-Pacific (Excluding Japan) (1)
Read the full report: http://www.reportlinker.com/p04484178-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article